Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 4
Submit an article Journal homepage
21
Views
7
CrossRef citations to date
0
Altmetric
Editorial

Progress, challenges and new genome-based concepts in the multidisciplinary treatment of gastric cancer

Christos Katsios Department of Surgery, Ioannina University School of Medicine, Ioannina, TK 451 10, Greece
,
George Baltogiannis Department of Surgery, Ioannina University School of Medicine, Ioannina, TK 451 10, Greece
&
Dimitrios H Roukos Department of Surgery, Ioannina University School of Medicine, Ioannina, TK 451 10, Greece and Personalized Cancer Networks Medicine, Biobank, Ioannina University, Ioannina, TK 451 10, Greece. [email protected]
Pages 503-506 | Published online: 10 Jan 2014

References

  • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer127(12), 2893–2917 (2010).
  • Jemal A, Siegel R, Xu JQ, Ward E. Cancer Statistics, 2010. CA Cancer J. Clin.60(5), 277–300 (2010).
  • Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol.24(14), 2137–2150 (2006).
  • Wu CW, Hsiung CA, Lo SS et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol.7(4), 309–315 (2006).
  • Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol.11(5), 439–449 (2010).
  • Paoletti X, Oba K, Burzykowski T et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA303(17), 1729–1737 (2010).
  • Sakuramoto S, Sasako M, Yamaguchi T et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N. Engl. J. Med.357(18), 1810–1820 (2007).
  • Cunningham D, Allum WH, Stenning SP et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N. Engl. J. Med.355(1), 11–20 (2006).
  • Schuhmacher C, Gretschel S, Lordick F et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954. J. Clin. Oncol.28(35), 5210–5218 (2010).
  • Ajani JA, Rodriguez W, Bodoky G et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J. Clin. Oncol.28(9), 1547–1553 (2010).
  • Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med.345(10), 725–730 (2001).
  • Baselga J, Swain SM. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer9(7), 463–475 (2009).
  • Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a Phase 3, open-label, randomised controlled trial. Lancet376(9742), 687–697 (2010).
  • Petrelli NJ, Winer EP, Brahmer J et al. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening – a report from the American Society of Clinical Oncology. J. Clin. Oncol.27(35), 6052–6069 (2009).
  • Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat. Rev. Cancer10(11), 760–774 (2010).
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell100, 57–70 (2000).
  • Heard E, Tishkoff S, Todd JA et al. Ten years of genetics and genomics: what have we achieved and where are we heading? Nat. Rev. Genet.11(10), 723–733 (2010).
  • Lander ES. Initial impact of the sequencing of the human genome. Nature470(7333), 187–197 (2011).
  • Roy S, Ernst J, Kharchenko PV et al. Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science330(6012), 1787–1797 (2010).
  • Tamsir A, Tabor JJ, Voigt CA. Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’. Nature469(7329), 212–215 (2010).
  • Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov.9(10), 775–789 (2010).
  • Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat. Biotechnol.28(10), 1069–1078 (2010).
  • Perry AS, Watson RW, Lawler M, Hollywood D. The epigenome as a therapeutic target in prostate cancer. Nat. Rev. Urol.7(12), 668–680 (2010).
  • de Bono JS, Ashworth A. Translating cancer research into targeted therapeutics. Nature467(7315), 543–549 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.